SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000912057-02-037134
Filing Date
2002-09-27
Accepted
2002-09-27 17:23:15
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G a2090019zsc13g.htm SC 13G 73211
3 EXHIBIT 1 a2090019zex-1.htm EX-1 12519
  Complete submission text file 0000912057-02-037134.txt   87963
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address
Business Address 800 E LEIGH ST SUITE 206 RICHMOND VA 23219 8088286893
INSMED INC (Subject) CIK: 0001104506 (see all company filings)

IRS No.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-59149 | Film No.: 02775291
SIC: 2834 Pharmaceutical Preparations